SI0804465T1 - Novel elastase inhibitors - Google Patents

Novel elastase inhibitors

Info

Publication number
SI0804465T1
SI0804465T1 SI9530682T SI9530682T SI0804465T1 SI 0804465 T1 SI0804465 T1 SI 0804465T1 SI 9530682 T SI9530682 T SI 9530682T SI 9530682 T SI9530682 T SI 9530682T SI 0804465 T1 SI0804465 T1 SI 0804465T1
Authority
SI
Slovenia
Prior art keywords
inhibitors
elastase inhibitors
elastase
compounds
novel elastase
Prior art date
Application number
SI9530682T
Other languages
English (en)
Slovenian (sl)
Inventor
William A. Metz Jr.
Steven L. Gallion
Joseph P. Burkhart
Michael R. Angelastro
Norton P. Peet
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of SI0804465T1 publication Critical patent/SI0804465T1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI9530682T 1994-06-02 1995-05-05 Novel elastase inhibitors SI0804465T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors
EP95918993A EP0804465B1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (1)

Publication Number Publication Date
SI0804465T1 true SI0804465T1 (en) 2003-12-31

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9530682T SI0804465T1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Country Status (20)

Country Link
EP (1) EP0804465B1 (ja)
JP (1) JP3623799B2 (ja)
KR (1) KR100347285B1 (ja)
CN (1) CN1149877A (ja)
AT (1) ATE246708T1 (ja)
AU (1) AU689589B2 (ja)
CA (1) CA2189527C (ja)
DE (1) DE69531459T2 (ja)
DK (1) DK0804465T3 (ja)
ES (1) ES2199992T3 (ja)
FI (1) FI964781A (ja)
HU (1) HU221197B1 (ja)
IL (1) IL113940A (ja)
NO (1) NO965097L (ja)
NZ (1) NZ285565A (ja)
PT (1) PT804465E (ja)
SI (1) SI0804465T1 (ja)
TW (1) TW403762B (ja)
WO (1) WO1995033763A1 (ja)
ZA (1) ZA954430B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100366328B1 (ko) * 1994-06-02 2003-03-06 메렐 파마슈티칼스 인크. 엘라스타제의퍼플루오로알킬케톤억제제및이들의제조방법
DK0762887T3 (da) * 1994-06-02 2002-01-14 Merrell Pharma Inc Acylerede enolderivater som prodrugs for elastase-hæmmere
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
EA009295B1 (ru) 2003-05-21 2007-12-28 Бёрингер Ингельхайм Интернациональ Гмбх Соединения в качестве ингибиторов вируса гепатита с
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
EP1771454B1 (en) 2004-07-20 2011-06-15 Boehringer Ingelheim International GmbH Hepatitis c inhibitor peptide analogs
WO2007137080A2 (en) 2006-05-23 2007-11-29 Irm Llc Compounds and compositions as channel activating protease inhibitors
JP2010518099A (ja) * 2007-02-09 2010-05-27 アイアールエム・リミテッド・ライアビリティ・カンパニー チャネル活性化プロテアーゼ阻害剤としての化合物および組成物
JP2023500182A (ja) 2019-09-17 2023-01-05 メレオ バイオファーマ 4 リミテッド 移植片拒絶反応、閉塞性細気管支炎症候群、及び移植片対宿主病の治療に使用するためのアルベレスタット
FI4106757T3 (fi) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Neutrofiilien elastaasin inhibiittori alvelestaattia sisältäviä menetelmiä alfa-1-antitrypsiinipuutoksen välittämän hengityselintaudin hoitamiseksi
CA3234399A1 (en) 2021-10-20 2023-04-27 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
WO1992012140A1 (en) * 1990-12-28 1992-07-23 Georgia Tech Research Corporation Peptides ketoamides, ketoacids, and ketoesters
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.

Also Published As

Publication number Publication date
HUT76926A (hu) 1998-01-28
ES2199992T3 (es) 2004-03-01
HU221197B1 (en) 2002-08-28
ZA954430B (en) 1996-02-13
CN1149877A (zh) 1997-05-14
KR100347285B1 (ko) 2003-01-15
AU689589B2 (en) 1998-04-02
WO1995033763A1 (en) 1995-12-14
ATE246708T1 (de) 2003-08-15
IL113940A0 (en) 1995-08-31
IL113940A (en) 1999-12-31
TW403762B (en) 2000-09-01
FI964781A0 (fi) 1996-11-29
AU2470995A (en) 1996-01-04
NO965097L (no) 1997-01-31
HU9603312D0 (en) 1997-01-28
EP0804465A1 (en) 1997-11-05
DE69531459T2 (de) 2004-06-24
PT804465E (pt) 2003-12-31
DE69531459D1 (de) 2003-09-11
MX9606030A (es) 1998-05-31
EP0804465B1 (en) 2003-08-06
CA2189527A1 (en) 1995-12-14
JP3623799B2 (ja) 2005-02-23
CA2189527C (en) 2000-12-19
NO965097D0 (no) 1996-11-29
DK0804465T3 (da) 2003-11-24
JPH10500992A (ja) 1998-01-27
NZ285565A (en) 1998-08-26
FI964781A (fi) 1997-01-29

Similar Documents

Publication Publication Date Title
BG105784A (en) Triazole compounds with dopamine-d3-receptor affinity
MX9706069A (es) Nuevos inhibidores de la trombina.
BG101112A (en) The use of heterocyclic compounds
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
GR3034208T3 (en) Human neutrophil elastase inhibitors
CA2189526A1 (en) Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
GB9806632D0 (en) Peptide factor
YU60900A (sh) Novi kristalni oblici antivirusnog benzimidazolskog jedinjenja
HU9603312D0 (en) Novel elastase inhibitors
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
GR3018304T3 (en) Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4h-pyran-4-ones.
BR9807883A (pt) Compostos de tetraidropirido
NZ330944A (en) Peptide derivatives
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
TR200003352T2 (tr) Yeni pentaerythrit türevleri, bunların imalatı ve kullanımları ile bunların sentezi için ara maddeler
MX9704796A (es) Peptidos novedosos, su preparacion y uso.
PE61999A1 (es) Compuestos de tetrahidropiridina